Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Revolution Medicines
Biotech
GSK chief steps down in stunning move—Chutes & Ladders
GSK chief steps down in stunning move. Cue queues up CEO transition. Quotient adds experienced drug developer.
Darren Incorvaia
,
Zoey Becker
Oct 3, 2025 8:30am
Revolution taps Iambic's AI models in $25M discovery deal
Jul 9, 2025 11:19am
Royalty signs off $2B to bankroll Revolution's RAS cancer drug
Jun 24, 2025 9:00am
AACR: KRAS inhibitors pop in preclinical data debuts
Apr 11, 2024 4:30am
The unraveling of EQRx's low-cost drug dream
Oct 5, 2023 10:47am
EQRx's low cost drug dream ends in Revolution
Aug 1, 2023 8:49am